Skip to content
Sign in
SWC 2026 FinalistGrand Final: Lunch Block

TERAMED SISTEMAS DE SAÚDE, SA

Angolan digital-health company offering corporate health management, 24/7 GP teleconsultation and hospital booking, still without public traction.

Luanda (Talatona), Angola, AfricaHealthTech, Access to care / patient-hospital matching
Stage
UndeterminedAI integrated
Product
PrototypeNone known
Funding raised
Undisclosedno funding
Founded
20242 years ago
Founders
1Carlos
Global score
3.0Grade DRank 126 of 151

Overview

Angolan digital health company founded in 2024 that connects patients and health professionals: Baika Corporate (employee health management for companies), 24/7 teleconsultation with general practitioners, and digital appointment booking for public and private hospitals and clinics (Baika+Saúde / SAT “Saúde ao Alcance de Todos” project).

Traction

None known

No public evidence of traction found; the Baika+Saúde platform is presented with no user figures or named partner hospitals.

Market

Telemedicine

Angola has limited access to doctors outside major cities and long waits in public hospitals, while companies need to manage employee health and absenteeism. Teleconsultation and digital booking can expand access, with employers and insurers as payers. The market is early, regulation of telemedicine is evolving, and trust plus doctor availability are key. Teramed has positioning but no disclosed users or hospital partners.

Addressable market

2025
$141.2B
2030
$380.3B
+17.6% a year

Telemedicine: $141bn (2024 base) to $380bn in 2030 (CAGR 17.6%, Grand View Research).

Customers

Employers (Baika Corporate), patients, public and private hospitals and clinics

Who signs the cheque

HR directors of companies; insurers; hospitals for booking

Geographies

  • Angola

Drivers

  • Access-to-care gaps
  • Corporate health and absenteeism costs
  • Mobile penetration

Headwinds

  • No traction
  • Opacity on team and partners
  • Telemedicine regulation and doctor supply

Global telemedicine market from $141bn (2024 base) to $380bn in 2030 (CAGR 17.6%) according to Grand View Research.

Scalability 4/10. Health service dependent on the hospital network and Angolan regulation; slow regional replication.

Market source: grandviewresearch.com

Technology

Category

Digital health platform (telemedicine and booking)

AI integratedMachine learning / predictive

Maturity

  1. R&D
  2. Prototype
  3. Pilot
  4. On the market
  5. Scaling

prototype

How it works

A web/mobile platform delivers teleconsultation, consultation booking for hospitals and clinics, and corporate health management. AI is mentioned without detail.

Moat

Weak: technology undisclosed; potential local relationships are the main asset.

Differentiation

Local Angolan positioning with a corporate offer.

Integration points

  • Hospital booking systems
  • Employer HR systems
  • White-label clinical platforms
  • Screening tools

Depends on

  • Doctor network
  • Hospital partnerships
  • Regulatory approval

Use of AI

The site lists artificial intelligence among its digital health tools, with no detail on its use.

Product in detail

Web/mobile platform for telemedicine, consultation booking and corporate health management.

Business

Model
Corporate subscriptions and consultation fees (assumed).
Revenue logic
Not disclosed.
Go-to-market
Corporate clients via Baika Corporate; public SAT project.

Next milestones

  1. First named corporate or hospital partner
  2. Launch of teleconsultation with volumes
  3. Seed funding

Key risks

  • No traction
  • Opacity
  • Execution

Opportunities

3 found in the network

Concrete moves for TERAMED SISTEMAS DE SAÚDE, SA inside the network: who to sell to, sell through, build with or raise from, each with the reasoning, the evidence and the first step.

  • Customers 1
  • Co-development 1
  • Investors 1

Customers1

Who could buy, or sell through

License TIBOK as a white-label engine for Baika

Instead of building its own stack, Teramed could run Baika+Saúde on TIBOK's white-label OS (own brand, WhatsApp and phone numbers, Portuguese workspace) with pay-per-consultation pricing. It accelerates launch and reduces capex; TIBOK gains an Angolan distributor.

40%confidence

Evidence from the records

  • “24/7 teleconsultation with general practitioners”
  • “distribute it under their own brand, on their own WhatsApp and phone numbers, with one workspace per client (country, language, time zone)”
  • “Eva Chat + My Medical Intelligence USD 1.20 per consultation”
If it works
A distributor agreement and launch with Baika Corporate clients.
First step
Request a TIBOK demo and the C-Care-style distributor terms.

Co-development1

An integration or joint product

Add photo-based anemia screening to corporate health checks

Anemia screening without blood tests suits Angolan corporate health programmes; Monere's smartphone eyelid-photo app could be bundled into Baika Corporate checks.

15%confidence

Evidence from the records

  • “Baika Corporate (employee health management for companies)”
  • “AI anemia detection solution that assesses risk in a few seconds, without a blood test.”
If it works
A differentiated corporate screening offer.
First step
Contact Monere to discuss a pilot licence for corporate screening.

Investors1

A fund whose thesis fits

Seek pre-seed/seed support from Boost Africa

Boost Africa supports Sub-Saharan HealthTech from pre-seed to Series A with an inclusion focus; Teramed must first show users and partners. No network warm path identified.

10%confidence

Evidence from the records

  • “Entrepreneurship and innovation for jobs and inclusion, with focus on youth, women and affordable products.”
  • “Need for access to care”
If it works
Early-stage capital for launch.
First step
Prepare traction metrics and contact Boost Africa's fund managers.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Investors that fit

African VC using tech and capital to leapfrog development, backing seed and Series A ventures that create jobs for women and youth.

Angolan patient-hospital matching — African health access; stage undetermined.

30%confidence

Evidence from the records

  • “Africa”
  • “Access to care / patient-hospital matching”
  • “No public evidence of traction found”

French-backed initiative for African tech founders, launching a ~€30M seed fund for about thirty start-ups in frontier ecosystems.

Angolan patient-hospital matching at prototype: frontier ecosystem but no traction.

20%confidence

Evidence from the records

  • “Access to care / patient-hospital matching”
  • “Angola”
First step
Build a hospital pilot first.

Madagascar's first impact fund for SMEs and start-ups, sponsored by Investisseurs & Partenaires, providing equity plus governance support.

Angolan patient-hospital matching — health, but no Madagascar link.

15%confidence

Evidence from the records

  • “Indian Ocean”
  • “Access to care / patient-hospital matching”
  • “No public evidence of traction found”

Investment analysis

3.0D

Grade D

Rank 126 of 151

Disruption3.0/10
Business model1.0/10
Market6.0/10
Risk(lower is better)9.0/10

Global score = mean of disruption, model, market and (11 − risk). Last updated 21 Nov 2026.

Not investable.

Disruption

3/10

Telehealth and patient-hospital matching: a known model.

Business model

1/10

No public traction.

Market

6/10

TAM telemedicine ~$141bn (base 7), low scalability 4/10 (−1), no proven international expansion (0) → 6/10.

Risk

9/10

Lower is better

Very high risk: no data, founders not named.

Strengths

  • Need for access to care
  • Corporate offering

Risks

  • No traction
  • Opacity

Funding

Undisclosed, no funding

Amount used in the study. No public funding round found.

Note. no public funding round found

Offering clarified from the site (Baika Corporate, 24/7 telemedicine, hospital booking); headquarters Edifício Prometeus, Talatona. No usage figures or SWC Angola qualification found.

Team

  • Carlos Marques

    CTO

    CTO of Teramed (founded in 2024); founders not publicly named.

Sources

Identification confidence
medium
  1. 1forbesafricalusofona.com/?p=171544
  2. 2verangola.net/va/en/042026/Events/48341/Teramed-Conference-2026-Conferenc
  3. 3teramed.ao/

From the open study Startup World Cup 2026 by TIBOK, based on public sources, verified in November 2026. Scores are an analyst's judgment on an explicit grid, not the jury's.

Wall

Wall

No posts yet